• Ph.D. in Mathematical Biology - Hebrew University of Jerusalem, Israel and Université Libre, Brussels, Belgium.
• M.Sc. in Genetics- Hebrew University of Jerusalem, Israel
• President of the Israeli Society for Theoretical and Mathematical Biology.
• Member of the Scientific Board of the European Society for Mathematical and Theoretical Biology ESMTB).
• Founder and president of the Institute for Medical Biomathematics (IMBM)
• Associate Editor of Wiley Series in Mathematical and Computational Biology.
• Associate Editor of the Journal of Biological Systems.
• Associate Editor - Journal of Mathematical Models and Methods in Applied Sciences (M3AS).

Karin holds a Ph.D degree in Molecular Biology from the Weizmann Institute of Science Rehovot. Her Ph.D thesis was in the field of molecular and cellular biology and focused on the proto-oncogene c-Myc: as a transcription factor, inducer of apoptosis and the control of its degradation. She joined IMBM in January 2008. In IMBM she takes part in the Cancer Stem Cell project.

Eva holds a Ph.D. degree in Applied Mathematics from the Weizmann Institute of Science Rehovot. Her Ph.D. research concerned mathematical modeling of autoimmune diseases. She joined IMBM in August 2006. In parallel to her research work at IMBM, Dr. Jager is a lecturer on the course of Mathematical modeling in cellular biology at the Holon Academic Institute of Technology. Her current focus of research at IMBM is modeling monoclonal antibody treatment of acute myeloid leukemia (AML).

Oleg holds a Ph.D. degree in algebra and number theory from the Kiev Taras Shevchenko National University (Ukraine). Dr. Kirnasovsky also studied Mathematics in the Mechanics and mathematics faculty at the Moscow Lomonosov University and teaching of mathematics and informatics in the Physics and mathematics faculty at the Vinnitsa Pedagogical University. His Ph.D. dissertation work involved binary and multiplace group isotopes. In IMBM Dr. Kirnasovsky is involved in the Marie Curie research project MRTN-CT-204-503661 "Using mathematical and computer simulation to improve cancer therapy" and the NEST research project “Developing a virtual and molecular control board for diverting cancer stem cell to non-malignance”

Natalie joined IMBM in March 2005 as a fellow of the Marie Curie research project MRTN-CT-204-503661 "Using mathematical and computer simulation to improve cancer therapy". She holds a Ph.D. in Plant Sciences from Tel Aviv University, on the subject of "Differentiation of the vascular system in conifers". She also holds a Ph.D. degree from the University of Minnesota, titled "Evolutionary games in space". It introduces spatial effects into game theory based evolutionarily stable strategies (ESS). The thesis was completed in the framework of the Conservation Biology graduate program at the University of Minnesota. In IMBM Natalie is involved in the malignant gliomas immunotherapy project as well as in the NEST Cancer Stem Cells project.

Lilach has completed her Ph.D studies at the Weizmann institute of science under the supervision of Prof. Moti Liscovitch in the department of biological regulation. Her thesis work has focused on experimentally studying the molecular mechanisms of caveolin-1 induction by PPAR? ligands in human cancer cells. Lilach has completed her B.Sc. and M.Sc. degrees in Tel-Aviv University in the faculty of Life Science. Her M.Sc. work in the department of Biochemistry in Tel Aviv University focused on experimentally studying Immunoglobulin light chains dictate vesicular transport-dependent and independent routes for IgM degradation by the ubiquitin-proteasome pathway. In IMBM, Lilach participates in the cancer stem cell project, theoretically studying the effects of various signal transduction pathways on stem cell proliferation.

Vladimir is a Medical Doctor at the Hadassah Medical Center in Jerusalem. He holds a B.Sc. degree in Medical Sciences from the Hebrew University, M.D. degree from the Hebrew University/ Hadassah Medical School and M.Sc. degree from the Department of Experimental Medicine and Cancer Research in the faculty of Medicine at the Hebrew University of Jerusalem. His M.Sc. research- carried out under the supervision of Prof. S.A. Ben-Sasson, involved the use of pathway inhibitors for the C-terminal post-translational modification of proteins, as a possible avenue for developing anti-angiogenesis therapy. Dr Vainstein is a fellow in Internal medicine Department at Hadassah Medical Center Campus Mt Scopus, Jerusalem. In IMBM he takes part in the immunotherapy project, investigating methods for improving the efficacy of monoclonal antibody drugs by mathemathically modeling the effects of such drugs on target and immune cells.

Moran Moran joined IMBM in November 2004, after completing a B.Sc. in Computational Biology at Bar-Ilan University. She is currently a PhD student in the School of Pharmacy at the Hebrew University of Jerusalem, under the supervision of Prof. Francesca Levi-Schaffer. In IMBM, Moran takes part in the Cancer Immunotherapy project.

Udi has completed his M.Sc studies in Mathematics at the Weizmann Institute, under the supervision of Professor Aviezri Fraenkel. His research area is Combinatorial Games and Number Theory. Udi has recently joined IMBM. At IMBM he is involved in Mathematical modeling of improved Interleukin-21 treatment schedules and in identifying new cancer therapy concepts. Scientific Activities

After completing his B.Sc studies in Life Science and Mathematics at the Hebrew University of Jerusalem Yuri spent two more years in studying Near Field microscope applications to micro-manipulations in biophysics, under the supervision of Prof Aharon Lewis of the Hebrew University of Jerusalem (see 1). Yuri holds M.Sc. degree in Applied Mathematics from the Technion, Israel Institute of Technology. His M.Sc. study involved mathematical combustion theory. In IMBM Yuri employs his skills in applied mathematics for developing mechanism based models of cancer drug therapy and its accompanied physiological side effects.

Yuri is studying for MA degree in mathematics, in the Einstein Institute of Mathematics in the Hebrew University, in Jerusalem. His current focus of research at IMBM is at modeling cancer growth and treatment, in particular immunotherapy of glioblastomas, and modelling of cancer stem cells, as a part of NEST project . Scientific Activities

Ofir holds a B.Sc degree from Holon institute for technology (H.I.T) - the department of applied mathematics. He has majored in two fields: biomathematics and signal processing. Ofir currently studies towards M.Sc degree in the department of applied mathematics at the University of Tel-Aviv. At IMBM Ofir is involved in brain tumor (glioblastoma) research, stem cell recruitment modeling and in image processing activity. Scientific Activities

Dorit is the Administrative Manager of IMBM. She holds a B.A. degree in English Literature and Information Science from Bar–Ilan University. Her primary responsibility is providing quality services to ensure successful finance and personnel management of IMBM members and visitors. The latter include Israeli and foreign scientists and students, engineering trainees, as well as post-doctorate students at IMBM. Dorit serves as administrative officer of two European research projects Marie Curie and NEST. The administrative unit supports the scientific activities and enables the wide base on which research is accomplished. In addition, Dorit acts as the administrator of the non-profit organization (which is the legal status of IMBM). She is in charge of organizing board meetings, preparing board minutes, budget and annual reports to the authorities involving the association Lawyers and accountants. The Administrator organizes and oversees the logistical activities in the office, procurement activities and staff workload oversight.

About IMBM | Scientific Board | IMBM Members | Research Projects | Applications
Join Us | Press Release | Events | Publications | HOME